ArticleIranian journal of pharmaceutical research : IJPR2020

Inhibition of Cyclin-dependent Kinase (CDK) Decreased Survival of NB4 Leukemic Cells: Proposing a p53-Independent Sensitivity of Leukemic Cells to Multi-CDKs Inhibitor AT7519.

Atieh Pourbagheri-Sigaroodi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.